Dec 30, 2020

Featuring a discussion on recent advances in the treatment of mesothelioma with Dr Marjorie Zauderer, including the following topics:

• Current mesothelioma management and future directions (0:00)
• Case: A man in his early 50s with epithelioid mesothelioma and a PD-L1 expression level of 20% receives cisplatin, pemetrexed and bevacizumab (25:41)
• Case: A man in his mid-60s with biphasic mesothelioma and a PD-L1 expression level of 80% receives nivolumab and ipilimumab (27:36)
• Case: A woman in her early 70s and a former smoker with diverticular disease and hypertension is diagnosed with epithelioid mesothelioma (28:51)

CME information and select publications